Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Use of Preemptive Pudendal Nerve Block Prior to Hydrodistention for the Treatment of Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)
Use of Preemptive Pudendal Nerve Block Prior to Hydrodistension for the Treatment of Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS): a Prospective, Double-blinded, Randomized Control Trial
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Bayview Medical Center
2304
mi
from 91732
Baltimore, MD
Use of Preemptive Pudendal Nerve Block Prior to Hydrodistention for the Treatment of Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)
Use of Preemptive Pudendal Nerve Block Prior to Hydrodistension for the Treatment of Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS): a Prospective, Double-blinded, Randomized Control Trial
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Bayview Medical Center
2304
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Mindfulness Intervention in Reducing Anxiety in Patients Who Have Been Treated for Gynecologic Cancer
Mindfulness-Based Interventions in Patients Treated for Gynecologic Cancer - Impact on Patient Reported Outcomes and Immunologic Correlates
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin Carbone Cancer Center
1654
mi
from 91732
Madison, WI
Mindfulness Intervention in Reducing Anxiety in Patients Who Have Been Treated for Gynecologic Cancer
Mindfulness-Based Interventions in Patients Treated for Gynecologic Cancer - Impact on Patient Reported Outcomes and Immunologic Correlates
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin Carbone Cancer Center
1654
mi
from 91732
Madison, WI
Click here to add this to my saved trials
Three New Ideas to Protect Special Forces From the Stress of High Altitude
Three New Ideas to Protect Special Forces From the Stress of High Altitude
Status: Enrolling
Updated:  12/31/1969
Alma College
1897
mi
from 91732
Alma, MI
Three New Ideas to Protect Special Forces From the Stress of High Altitude
Three New Ideas to Protect Special Forces From the Stress of High Altitude
Status: Enrolling
Updated: 12/31/1969
Alma College
1897
mi
from 91732
Alma, MI
Click here to add this to my saved trials
The Use of an Open Label Placebo to Treat Cancer Related Fatigue in Cancer Survivors
The Use of an Open Label Placebo to Treat Cancer Related Fatigue in Cancer Survivors
Status: Enrolling
Updated:  12/31/1969
UAB Comprehensive Cancer Center
1785
mi
from 91732
Birmingham, AL
The Use of an Open Label Placebo to Treat Cancer Related Fatigue in Cancer Survivors
The Use of an Open Label Placebo to Treat Cancer Related Fatigue in Cancer Survivors
Status: Enrolling
Updated: 12/31/1969
UAB Comprehensive Cancer Center
1785
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
Efficacy of Amicar for Children Having Craniofacial Surgery
Efficacy of ε-Aminocaproic Acid (EACA) in Children Undergoing Craniofacial Reconstruction Surgery
Status: Enrolling
Updated:  12/31/1969
Childrens National Medical Center
2281
mi
from 91732
Washington,
Efficacy of Amicar for Children Having Craniofacial Surgery
Efficacy of ε-Aminocaproic Acid (EACA) in Children Undergoing Craniofacial Reconstruction Surgery
Status: Enrolling
Updated: 12/31/1969
Childrens National Medical Center
2281
mi
from 91732
Washington,
Click here to add this to my saved trials
Cochlear Implantation for Treatment of Single-sided Deafness
Cochlear Implantation for Treatment of Single-sided Deafness
Status: Enrolling
Updated:  12/31/1969
Massachusetts Eye & Ear Infirmary
2578
mi
from 91732
Boston, MA
Cochlear Implantation for Treatment of Single-sided Deafness
Cochlear Implantation for Treatment of Single-sided Deafness
Status: Enrolling
Updated: 12/31/1969
Massachusetts Eye & Ear Infirmary
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Pediatric Pharmacokinetic (PK) Study of EXE844 Otic Suspension in Otitis Media at the Time of Tympanostomy Tube Insertion (OMTT)
An Open-Label, Single-Dose, Pharmacokinetic Study of EXE844 Sterile Otic Suspension, 0.3% in Pediatric Subjects Following Tympanostomy Tube Surgery
Status: Enrolling
Updated:  12/31/1969
Contact Alcon Call Center for Trial Locations
1194
mi
from 91732
Fort Worth, TX
Pediatric Pharmacokinetic (PK) Study of EXE844 Otic Suspension in Otitis Media at the Time of Tympanostomy Tube Insertion (OMTT)
An Open-Label, Single-Dose, Pharmacokinetic Study of EXE844 Sterile Otic Suspension, 0.3% in Pediatric Subjects Following Tympanostomy Tube Surgery
Status: Enrolling
Updated: 12/31/1969
Contact Alcon Call Center for Trial Locations
1194
mi
from 91732
Fort Worth, TX
Click here to add this to my saved trials
Interstitial Cystitis (IC)-Like Findings With Hydrodistension
Correlation Between Urinary Symptoms and Interstitial Cystitis (IC)-Like Findings on Cystoscopy With Hydrodistension
Status: Enrolling
Updated:  12/31/1969
St. Mary's Health Center
1567
mi
from 91732
Saint Louis, MO
Interstitial Cystitis (IC)-Like Findings With Hydrodistension
Correlation Between Urinary Symptoms and Interstitial Cystitis (IC)-Like Findings on Cystoscopy With Hydrodistension
Status: Enrolling
Updated: 12/31/1969
St. Mary's Health Center
1567
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
A Study to Assess the Efficacy of Skin Rejuvenation Therapy in Combination With Neurotoxin and Full Facial Filler Treatments
A Post-market, Randomized Study to Assess the Efficacy of Skin Rejuvenation Therapy in Combination With Neurotoxin and Full Facial Filler Treatments
Status: Enrolling
Updated:  12/31/1969
DeNova Research
1730
mi
from 91732
Chicago, IL
A Study to Assess the Efficacy of Skin Rejuvenation Therapy in Combination With Neurotoxin and Full Facial Filler Treatments
A Post-market, Randomized Study to Assess the Efficacy of Skin Rejuvenation Therapy in Combination With Neurotoxin and Full Facial Filler Treatments
Status: Enrolling
Updated: 12/31/1969
DeNova Research
1730
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms
A Phase 2 Study to Assess the Efficacy and Safety of Cannabidiol Oral Solution for the Treatment of Refractory Infantile Spasms
Status: Enrolling
Updated:  12/31/1969
Mattel Children's Hospital at UCLA
25
mi
from 91732
Los Angeles, CA
Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms
A Phase 2 Study to Assess the Efficacy and Safety of Cannabidiol Oral Solution for the Treatment of Refractory Infantile Spasms
Status: Enrolling
Updated: 12/31/1969
Mattel Children's Hospital at UCLA
25
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms
A Phase 2 Study to Assess the Efficacy and Safety of Cannabidiol Oral Solution for the Treatment of Refractory Infantile Spasms
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
356
mi
from 91732
San Francisco, CA
Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms
A Phase 2 Study to Assess the Efficacy and Safety of Cannabidiol Oral Solution for the Treatment of Refractory Infantile Spasms
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
356
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms
A Phase 2 Study to Assess the Efficacy and Safety of Cannabidiol Oral Solution for the Treatment of Refractory Infantile Spasms
Status: Enrolling
Updated:  12/31/1969
Miami Children's Hospital
2316
mi
from 91732
Miami, FL
Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms
A Phase 2 Study to Assess the Efficacy and Safety of Cannabidiol Oral Solution for the Treatment of Refractory Infantile Spasms
Status: Enrolling
Updated: 12/31/1969
Miami Children's Hospital
2316
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms
A Phase 2 Study to Assess the Efficacy and Safety of Cannabidiol Oral Solution for the Treatment of Refractory Infantile Spasms
Status: Enrolling
Updated:  12/31/1969
Beaumont Health System
1961
mi
from 91732
Royal Oak, MI
Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms
A Phase 2 Study to Assess the Efficacy and Safety of Cannabidiol Oral Solution for the Treatment of Refractory Infantile Spasms
Status: Enrolling
Updated: 12/31/1969
Beaumont Health System
1961
mi
from 91732
Royal Oak, MI
Click here to add this to my saved trials
Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations
Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations
Status: Enrolling
Updated:  12/31/1969
Massachusetts Eye and Ear
2576
mi
from 91732
Boston, MA
Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations
Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations
Status: Enrolling
Updated: 12/31/1969
Massachusetts Eye and Ear
2576
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations
Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations
Status: Enrolling
Updated:  12/31/1969
Wilford Hall, Lackland Airforce Base
1182
mi
from 91732
Lackland Air Force Base, TX
Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations
Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations
Status: Enrolling
Updated: 12/31/1969
Wilford Hall, Lackland Airforce Base
1182
mi
from 91732
Lackland Air Force Base, TX
Click here to add this to my saved trials
Oxidative Stress-Related Biomarkers in Gaucher Disease: A Preliminary Study
Oxidative Stress-Related Biomarkers in Gaucher Disease: A Preliminary Study
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
1511
mi
from 91732
Minneapolis, MN
Oxidative Stress-Related Biomarkers in Gaucher Disease: A Preliminary Study
Oxidative Stress-Related Biomarkers in Gaucher Disease: A Preliminary Study
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
1511
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
Clinical Investigation of a New Bulk Fill Composite Resin in the Restoration of Posterior Teeth
Clinical Investigation of a New Bulk Fill Composite Resin in the Restoration of Posterior Teeth
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill School of Dentistry
2194
mi
from 91732
Chapel Hill, NC
Clinical Investigation of a New Bulk Fill Composite Resin in the Restoration of Posterior Teeth
Clinical Investigation of a New Bulk Fill Composite Resin in the Restoration of Posterior Teeth
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill School of Dentistry
2194
mi
from 91732
Chapel Hill, NC
Click here to add this to my saved trials
The Effects Upon the Bladder of Transcutaneous Tibial Nerve Stimulation in Acute Traumatic Spinal Cord Injury
The Effects Upon the Bladder of Transcutaneous Tibial Nerve Stimulation in Acute Traumatic Spinal Cord Injury
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at Houston
1352
mi
from 91732
Houston, TX
The Effects Upon the Bladder of Transcutaneous Tibial Nerve Stimulation in Acute Traumatic Spinal Cord Injury
The Effects Upon the Bladder of Transcutaneous Tibial Nerve Stimulation in Acute Traumatic Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston
1352
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Adipose Derived Stem Cells in Facial Fat Grafting
A Phase II Double-blind, Randomized, Study to Assess the Efficacy of Facial Fat Grafts Supplemented With Autologous, Adipose Derived Stromal Vascular Fraction (SVF)
Status: Enrolling
Updated:  12/31/1969
Delmont Surgery Center
2141
mi
from 91732
Delmont, PA
Adipose Derived Stem Cells in Facial Fat Grafting
A Phase II Double-blind, Randomized, Study to Assess the Efficacy of Facial Fat Grafts Supplemented With Autologous, Adipose Derived Stromal Vascular Fraction (SVF)
Status: Enrolling
Updated: 12/31/1969
Delmont Surgery Center
2141
mi
from 91732
Delmont, PA
Click here to add this to my saved trials
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared With the Individual Components Lidocaine and Heparin in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
IC Study, LLC
84
mi
from 91732
Escondido, CA
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared With the Individual Components Lidocaine and Heparin in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
IC Study, LLC
84
mi
from 91732
Escondido, CA
Click here to add this to my saved trials
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared With the Individual Components Lidocaine and Heparin in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
University of California, San Diego
99
mi
from 91732
San Diego, CA
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared With the Individual Components Lidocaine and Heparin in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
University of California, San Diego
99
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared With the Individual Components Lidocaine and Heparin in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
Georgia Urology
1891
mi
from 91732
Cartersville, GA
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared With the Individual Components Lidocaine and Heparin in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Georgia Urology
1891
mi
from 91732
Cartersville, GA
Click here to add this to my saved trials
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared With the Individual Components Lidocaine and Heparin in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
The Urogynecology Center
1335
mi
from 91732
Overland Park, KA
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared With the Individual Components Lidocaine and Heparin in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
The Urogynecology Center
1335
mi
from 91732
Overland Park, KA
Click here to add this to my saved trials
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared With the Individual Components Lidocaine and Heparin in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
The Arthur Smith Institue for Urology- North Shore Long Island Jewish Health System
2447
mi
from 91732
Lake Success, NY
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared With the Individual Components Lidocaine and Heparin in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
The Arthur Smith Institue for Urology- North Shore Long Island Jewish Health System
2447
mi
from 91732
Lake Success, NY
Click here to add this to my saved trials
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared With the Individual Components Lidocaine and Heparin in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
Wake Forest University Health Sciences
2129
mi
from 91732
Winston-Salem, NC
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared With the Individual Components Lidocaine and Heparin in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Wake Forest University Health Sciences
2129
mi
from 91732
Winston-Salem, NC
Click here to add this to my saved trials
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared With the Individual Components Lidocaine and Heparin in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
MetroHealth System, Center for Advanced Gynecology
2032
mi
from 91732
Cleveland, OH
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared With the Individual Components Lidocaine and Heparin in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
MetroHealth System, Center for Advanced Gynecology
2032
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared With the Individual Components Lidocaine and Heparin in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
2184
mi
from 91732
Charleston, SC
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared With the Individual Components Lidocaine and Heparin in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
2184
mi
from 91732
Charleston, SC
Click here to add this to my saved trials
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared With the Individual Components Lidocaine and Heparin in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
Sanford Research
1316
mi
from 91732
Sioux Falls, SD
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared With the Individual Components Lidocaine and Heparin in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Sanford Research
1316
mi
from 91732
Sioux Falls, SD
Click here to add this to my saved trials
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared With the Individual Components Lidocaine and Heparin in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
Urology of Virginia, PLLC
2350
mi
from 91732
Virginia Beach, VA
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared With the Individual Components Lidocaine and Heparin in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Urology of Virginia, PLLC
2350
mi
from 91732
Virginia Beach, VA
Click here to add this to my saved trials
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared With the Individual Components Lidocaine and Heparin in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
Rutgers Women's Health Clinic
mi
from 91732
New Brunswick, NJ
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared With the Individual Components Lidocaine and Heparin in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Rutgers Women's Health Clinic
mi
from 91732
New Brunswick, NJ
Click here to add this to my saved trials
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated:  12/31/1969
Indiana University School of Dentistry
1793
mi
from 91732
Indianapolis, IN
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Indiana University School of Dentistry
1793
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated:  12/31/1969
John F. Pittaway, DMD
993
mi
from 91732
Kalispell, MT
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
John F. Pittaway, DMD
993
mi
from 91732
Kalispell, MT
Click here to add this to my saved trials
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated:  12/31/1969
Plaza West II Dental Group
994
mi
from 91732
Kalispell, MT
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Plaza West II Dental Group
994
mi
from 91732
Kalispell, MT
Click here to add this to my saved trials
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated:  12/31/1969
New York University College of Dentistry
2434
mi
from 91732
New York, NY
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
New York University College of Dentistry
2434
mi
from 91732
New York, NY
Click here to add this to my saved trials
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated:  12/31/1969
University of Pennsylvania School of Dental Medicine
2375
mi
from 91732
Philadelphia, PA
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
University of Pennsylvania School of Dental Medicine
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated:  12/31/1969
Anthony Henegar, DDS, PA
1211
mi
from 91732
Irving, TX
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Anthony Henegar, DDS, PA
1211
mi
from 91732
Irving, TX
Click here to add this to my saved trials
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated:  12/31/1969
Imperial Beach Family Dentistry
115
mi
from 91732
Imperial Beach, CA
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Imperial Beach Family Dentistry
115
mi
from 91732
Imperial Beach, CA
Click here to add this to my saved trials
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated:  12/31/1969
Tufts University
2578
mi
from 91732
Boston, MA
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Tufts University
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated:  12/31/1969
East Carolina University
2290
mi
from 91732
Greenville, NC
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
East Carolina University
2290
mi
from 91732
Greenville, NC
Click here to add this to my saved trials
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated:  12/31/1969
Texas Baylor College of Dentistry
1225
mi
from 91732
Dallas, TX
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Texas Baylor College of Dentistry
1225
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
1777
mi
from 91732
Birmingham, AL
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
1777
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
University of Southern California
11
mi
from 91732
Los Angeles, CA
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
University of Southern California
11
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
356
mi
from 91732
San Francisco, CA
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
356
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
University of Colorado Denver
825
mi
from 91732
Aurora, CO
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
University of Colorado Denver
825
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
Yale University
2486
mi
from 91732
New Haven, CT
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
Yale University
2486
mi
from 91732
New Haven, CT
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
Tampa General Hospital
2136
mi
from 91732
Tampa, FL
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
Tampa General Hospital
2136
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
Ochsner Medical Center
1650
mi
from 91732
New Orleans, LA
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
Ochsner Medical Center
1650
mi
from 91732
New Orleans, LA
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
University of Maryland
2301
mi
from 91732
Baltimore, MD
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
University of Maryland
2301
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
St. Barnabas Medical Center
2416
mi
from 91732
Livingston, NJ
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
St. Barnabas Medical Center
2416
mi
from 91732
Livingston, NJ
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
Icahn School of Medicine at Mt Sinai
2435
mi
from 91732
New York, NY
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
Icahn School of Medicine at Mt Sinai
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials